Walts Alan Edmund 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
Walts Alan Edmund
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-01+37,695→ 37,695 total - Exercise/Conversion
Restricted Stock Units
2021-12-01−37,695→ 0 total→ Common Stock (37,695 underlying)
Footnotes (3)
- [F1]The restricted stock units issued to the reporting person on April 1, 2021 have fully vested and settled for shares of the Issuer's common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan.